Clinical trial
Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in…
NCT00462501 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00462501 |
|---|---|
| Title | Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer |
| Official title | A Pilot Study of Neoadjuvant Chemotherapy With Selective Use of Radiation for Locally Advanced Rectal Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Genentech, Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | bevacizumab, fluorouracil, leucovorin calcium, oxaliplatin, conventional surgery, radiation therapy |
| Enrollment | 35 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2014 |
| Completion | Feb 1, 2014 |
| First posted | Apr 19, 2007 |
| Last update posted | Jan 20, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: